CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-11 | ROBERTSON SANFORD Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-09-24 | BARBIER REMI President and CEO | Purchase | +10,000 | $9.59 | $96K | 1,078,855 |
| 2020-09-18 | ROBERTSON SANFORD Director | Purchase | +36,281 | $8.92 | $324K | 912,623 |
| 2020-09-17 | Schoen Eric Chief Financial Officer | Purchase | +10,000 | $7.03 | $70K | 25,300 |
| 2020-09-17 | Schoen Eric Chief Financial Officer | Purchase | +2,000 | $7.04 | $14K | 27,300 |
| 2020-09-17 | ROBERTSON SANFORD Director | Purchase | +213,719 | $6.98 | $1.5M | 876,342 |
| 2019-12-31 | BARBIER REMI President and CEO | Purchase | +100,000 | $5.53 | $553K | 1,068,855 |
| 2019-12-26 | BARBIER REMI President and CEO | Purchase | +10,000 | $4.15 | $42K | 968,855 |
| 2019-12-20 | ROBERTSON SANFORD Director | Purchase | +423,788 | $2.20 | $932K | 662,623 |
| 2019-12-19 | Schoen Eric Chief Financial Officer | Purchase | +5,300 | $1.88 | $10K | 15,300 |
| 2019-12-19 | ROBERTSON SANFORD Director | Purchase | +76,212 | $1.86 | $142K | 238,835 |
| 2019-12-18 | BARBIER REMI President and CEO | Purchase | +2,599 | $1.65 | $4K | 958,855 |
| 2019-12-18 | BARBIER REMI President and CEO | Purchase | +2,599 | $1.65 | $4K | 2,599 |
| 2019-12-13 | GUSSIN ROBERT Z Director | Grant or award · Stock option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-12-13 | SCANNON PATRICK J MD PHD Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-12-13 | ROBERTSON SANFORD Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-12-13 | Ramasastry Saira Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2019-12-13 | O DONNELL MICHAEL J Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-12-13 | FRIEDMANN NADAV Chief Medical & Operating Off. | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-12-13 | BARBIER REMI President and CEO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 9 of 17 · 324 trades